Axogen (AXGN) Cash from Operations Growth (3y) (2013 - 2026)
Axogen (AXGN) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.22 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.20 Bn | 125.32 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 107.69 Bn | 98.47 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.05 Bn | 66.59 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 47.52 Bn | 43.85 Bn | 1.29 Bn | -48.14% |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.17 Bn | 1.98 Bn | -14.75% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | 50.11% |
| 8 | Smith & Nephew | 26.73 Bn | 26.15 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 0.50% |
| 10 | Axogen | 2.10 Bn | 1.99 Bn | 46.19 Mn | 30.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.27% |
| Dec 31, 2025 | 30.66% |
| Sep 30, 2025 | 88.31% |
| Jun 30, 2025 | 49.76% |
| Mar 31, 2025 | -6.05% |
| Dec 31, 2024 | 98.06% |
| Sep 30, 2024 | 131.30% |
| Jun 30, 2024 | 99.94% |
| Mar 31, 2024 | -4.27% |
| Dec 31, 2023 | -27.53% |
| Sep 30, 2023 | -14.68% |
| Jun 30, 2023 | 26.86% |
| Mar 31, 2023 | 2.67% |
| Dec 31, 2022 | 34.05% |
| Sep 30, 2022 | 28.23% |
| Jun 30, 2022 | 0.71% |
| Mar 31, 2022 | -7.62% |
| Dec 31, 2021 | 32.74% |
| Sep 30, 2021 | 49.77% |
| Jun 30, 2021 | 44.55% |